Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Universitaire Ziekenhuizen KU Leuven
Obesity with insulin resistance in the paediatric population provides an increasing challenge. Children with neurological or neuromuscular diseases are even more prone to obesity: their locomotor impairment leads to an increasingly sedentary lifestyle, a decrease in physical fitness and an increase in body fat (1-3). Obesity, in turn, can be associated with a decrease in physical fitness and a further increase in body fat. In this study we want to evaluate the effect of an insulin-sensitizer, metformin, in a group of overweight/obese patients with neurological or neuromuscular diseases. Metformin is a well-established insulin sensitizer.
Age
8–35
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with neurogenic or myogenic motor deficit, clinically obese or who had excessively gained weight over the last year.